AXS-05: an investigational treatment for Alzheimer’s disease-associated agitation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AXS-05: an investigational treatment for Alzheimer’s disease-associated agitation
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 31, Issue 8, Pages 773-780
Publisher
Informa UK Limited
Online
2022-06-29
DOI
10.1080/13543784.2022.2096006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PharmVar GeneFocus: CYP2B6
- (2021) Zeruesenay Desta et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Rapid Effects of AXS-05, an Oral NMDA Receptor Antagonist, in Major Depressive Disorder: Results From Two Randomized, Double-Blind, Controlled Trials
- (2021) Cedric O'Gorman et al. BIOLOGICAL PSYCHIATRY
- Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
- (2021) Claudia Carrarini et al. Frontiers in Neurology
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- (2021) Sube Banerjee et al. LANCET
- Deuterated dextromethorphan/quinidine for agitation in Alzheimer’s disease
- (2021) Rita Khoury Neural Regeneration Research
- Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta‐analysis
- (2021) Seenae Eum et al. PHARMACOTHERAPY
- Analysis of risk factors for depression in Alzheimer’s disease patients
- (2020) Hai Yang et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Psychosis in Alzheimer’s Disease
- (2020) Clive Ballard et al. Current Neurology and Neuroscience Reports
- Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects
- (2019) Rafaela Costa et al. DRUG METABOLISM REVIEWS
- Determinants of self‐ and carer‐rated quality of life and caregiver burden in Alzheimer disease
- (2019) Christin Schumann et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Sequential drug treatment algorithm for agitation and aggression in Alzheimer’s and mixed dementia
- (2018) Simon JC Davies et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Seizure in Alzheimer’s Disease: An Underestimated Phenomenon
- (2018) Marjan Asadollahi et al. American Journal of Alzheimers Disease and Other Dementias
- Epileptic Seizures Under Antidepressive Drug Treatment: Systematic Review
- (2017) Tilman Steinert et al. PHARMACOPSYCHIATRY
- Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model
- (2017) Caifu Xue et al. Pharmaceutics
- AVP-786 for the treatment of agitation in dementia of the Alzheimer’s type
- (2016) Ricardo P. Garay et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis
- (2016) Qing-Fei Zhao et al. JOURNAL OF AFFECTIVE DISORDERS
- Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders
- (2016) Linda Nguyen et al. PHARMACOLOGY & THERAPEUTICS
- Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use
- (2016) Charles P. Taylor et al. PHARMACOLOGY & THERAPEUTICS
- Prevalence of and factors related to mild and substantial dizziness in community-dwelling older adults: a cross-sectional study
- (2016) Ann-Sofi C. Kammerlind et al. BMC Geriatrics
- Use of Benzodiazepines in Alzheimer’s Disease: A Systematic Review of Literature
- (2015) Michaela Defrancesco et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia
- (2015) Jeffrey L. Cummings et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition
- (2014) Jeffrey Cummings et al. INTERNATIONAL PSYCHOGERIATRICS
- Effect of Citalopram on Agitation in Alzheimer Disease
- (2014) Anton P. Porsteinsson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dextromethorphan/levomethorphan issues in a case of opiate overdose
- (2013) Federica Bortolotti et al. Drug Testing and Analysis
- Bupropion-induced psychosis: folklore or a fact? A systematic review of the literature
- (2011) Sanjeev Kumar et al. GENERAL HOSPITAL PSYCHIATRY
- Neuropsychiatric Symptoms and Syndromes in a Large Cohort of Newly Diagnosed, Untreated Patients With Alzheimer Disease
- (2010) Gianfranco Spalletta et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Determinants of Quality of Life in Nursing Home Residents with Dementia
- (2010) R.B. Wetzels et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?
- (2009) Hugo R. Arias INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Dextromethorphan abuse: Clinical effects and management
- (2009) Frank Romanelli et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now